Kahn, J. M., Pei, Q., Friedman, D. L., Kaplan, J., Keller, F. G., Hodgson, D., Wu, Y., Appel, B. E., Bhatia, S., Henderson, T. O., Schwartz, C. L., Kelly, K. M., & Castellino, S. M. (2022). Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children’s oncology group trials. The Lancet Haematology, 9(1), e49–e57. https://doi.org/10.1016/s2352-3026(21)00349-5

Petridis, P. D., Horenstein, C. I., Pereira, B., Wu, P. B., Samanamud, J., Marie, T., Boyett, D., Sudhakar, T. D., Sheth, S. A., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P., & Grinband, J. (2021). BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas. Neuro-Oncology, 24(1), 78–87. https://doi.org/10.1093/neuonc/noab154

Rodriguez-Hernandez, A., & Kahn, J. M. (2022). Improving Health Equity and Reducing Pediatric Cancer Disparities: The Role of the Medical Home. Pediatric Annals, 51(1). https://doi.org/10.3928/19382359-20211207-02

Menolfi, D., & Zha, S. (2022). DNA-PKcs kinase activity orchestrates both end-processing and end-ligation. Trends in Cell Biology, 32(2), 91–93. https://doi.org/10.1016/j.tcb.2021.12.002

Youn, M., Smith, S. M., Lee, A. G., Chae, H.-D., Spiteri, E., Erdmann, J., Galperin, I., Jones, L. M., Donato, M., Abidi, P., Bittencourt, H., Lacayo, N., Dahl, G., Aftandilian, C., Davis, K. L., Matthews, J. A., Kornblau, S. M., Huang, M., Sumarsono, N., … Sakamoto, K. M. (2021). Comparison of the Transcriptomic Signatures in Pediatric and Adult CML. Cancers, 13(24), 6263. https://doi.org/10.3390/cancers13246263

Smith, S. M., Zhang, S., Sundaram, V., Roth, M., Andolina, J. R., Schapira, L., Sakamoto, K. M., Kolb, E. A., Hijiya, N., & Chaudhury, S. (2021). Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. Pediatric Hematology and Oncology, 39(5), 453–467. https://doi.org/10.1080/08880018.2021.2017085

Kahn, J. M., Maguire, F. B., Li, Q., Abrahão, R., Flerlage, J. E., Alvarez, E., & Keegan, T. H. M. (2021). Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population‐based study. Cancer, 127(24), 4613–4619. Portico. https://doi.org/10.1002/cncr.33868

Hitzler, J., Alonzo, T., Gerbing, R., Beckman, A., Hirsch, B., Raimondi, S., Chisholm, K., Viola, S., Brodersen, L., Loken, M., Tong, S., Druley, T., O’Brien, M., Hijiya, N., Heerema-McKenney, A., Wang, Y.-C., Shore, R., Taub, J., Gamis, A., … Berman, J. N. (2021). High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial. Blood, 138(23), 2337–2346. https://doi.org/10.1182/blood.2021012206

Steinberg, D. M., Andresen, J. A., Pahl, D. A., Licursi, M., & Rosenthal, S. L. (2021). “I’ve Weathered Really Horrible Storms Long Before This…”: The Experiences of Parents Caring for Children with Hematological and Oncological Conditions during the Early Months of the COVID-19 Pandemic in the U.S. Journal of Clinical Psychology in Medical Settings, 28(4), 720–727. https://doi.org/10.1007/s10880-020-09760-2

Kennedy, A. L., Myers, K. C., Bowman, J., Gibson, C. J., Camarda, N. D., Furutani, E., Muscato, G. M., Klein, R. H., Ballotti, K., Liu, S., Harris, C. E., Galvin, A., Malsch, M., Dale, D., Gansner, J. M., Nakano, T. A., Bertuch, A., Vlachos, A., Lipton, J. M., … Lindsley, R. C. (2021). Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-21588-4